CDX2 expression, while common in GI neoplasms, can also be focally or diffusely positive in gynecological malignancies, potentially leading to diagnostic errors if interpreted alone, particularly in tumors of uncertain primary origin
Who Can Receive Weight Loss Medications FDA-approved weight loss medications are typically prescribed to adults with a BMI of 30 or higher or a BMI of 27 with coexisting conditions such as type 2 diabetes
The Precision Peptide Genetic Test analyzes 49 peptides across 14 pathways, including variants in GLP1R, GIPR, FTO, and MC4R that influence weight loss speed and side effect sensitivity
Forino, M., Gambuti, A., Luciano, P
Severity Rating and Clinical Classification No formal DDI database (Lexicomp, Clinical Pharmacology, Micromedex) includes BPC-157 because it is not an FDA-approved drug
[Mortality associated with oral contraceptive use: 25-year follow-up of a cohort of 46,000 women from Royal College of General Practitionerss oral Contraception study